?? Exciting news for #BreastCancer treatment! Dr. Kevin Kalinsky, of Winship Cancer Institute of Emory University, breaks down what patients need to know about Itovebi, when combined with Ibrance and Faslodex. #BreastCancer #MedEd Read more here: https://hubs.ly/Q03fdnsm0
关于我们
Curetoday.com and CURE magazine, our free publication, are the leading resources for patients with cancer, survivors and their caregivers to become empowered advocates in their journeys. We deliver cancer updates, research and education to help make cancer understandable during every stage of the experience and connect the cancer community.
- 网站
-
https://www.curetoday.com
CURE?的外部链接
- 所属行业
- 图书期刊出版业
- 规模
- 11-50 人
- 总部
- Cranbury，New Jersey
- 类型
- 私人持股
- 领域
- books和resource guide, interactive website
地点
-
主要
获取路线
2 Clarke Dr
US，New Jersey，Cranbury，08512
CURE?员工
-
Sonya Collins
Independent journalist/editor covering health care & medical research; public speaker & instructor; fluent Portuguese.
-
Curtis Smith
Bussiness Owner
-
Jeremy Pivor
Partnerships & Youth Engagement Director at Bow Seat Ocean Awareness Programs // Healthcare advocate, writer, and speaker
-
Tamera Anderson-Hanna
Licensed Mental Health Professional, Corporate and Personal Wellness Advisor Published Writer
动态
-
Join us for CURE’s Educated Patient Young-Onset Lung Cancer Summit—a free, virtual event created to support and empower younger lung cancer patients, survivors, and caregivers. Connect with the lung cancer community and learn from experts, like Eric Singhi, MD @lungoncdoc, about the latest in cancer care. Join us online on Saturday, April 26! #EducatedPatient #LungCancer ?? Learn more & register today! https://hubs.li/Q03f6pnR0 In partnership with: Young Lung Cancer Initiative, ICAN, International Cancer Advocacy Network, LiveLung, GO2 for Lung Cancer
-
-
In honor of #ColorectalCancerAwarenessMonth, Melissa Ursini, of Santa Clarita, California, sat down for an interview with CURE to discuss her experience with a #ColonCancer diagnosis at age 37. City of Hope #MedEd #Oncology Read more from Melissa here: https://hubs.ly/Q03dVc5T0
-
We're celebrating 10 Days of Extraordinary Healers on CURE’s Facebook! In the lead-up to this year’s Extraordinary Healer? award for oncology nursing, we’re honoring a decade of incredible oncology nurses who have made a lasting impact. Each day, we’ll spotlight past honorees and their inspiring stories, leading up to the big winner reveal on April 9 at #ONSCongress! Check out our 2015 winner here: https://lnkd.in/d7hp3QCV Follow along as we count down with more incredible stories! #EH25 #oncologynursing
CURE & Oncology Nursing News are proud to announce the finalists for the 2025 Extraordinary Healer award for oncology nursing! These outstanding oncology nurses go above and beyond to provide exceptional care: ?? Kathleen Coughlin, MSN, ANP-BC, BMTCN – Tufts Medical Center ?? Matthew Mangold, BSN, RN – Fox Chase Cancer Center ?? Kaifan Zhao, AGACNP-BC, PMHNP-BC – City of Hope We’re also thrilled to welcome Amy Robach —award-winning journalist and cancer awareness advocate—as our keynote speaker! Join us April 9 at #ONSCongress as we celebrate these extraordinary nurses. ?? Learn more about our finalists here: https://hubs.li/Q03dz1Ls0 #EH25 #oncologynursing #ONS
-
-
ICYMI: The Food and Drug Administration has approved Stoboclo and Osenvelt to address skeletal issues faced by patients with cancer. #Oncology Read more here: https://hubs.li/Q03dRX100
-
-
?? Advancing #BreastCancer Treatment: What Patients Need to Know #BreastCancerCare is evolving with gene expression testing and targeted therapies, helping refine treatment decisions and improve outcomes, according to Dr. Sara Tolaney, of Dana-Farber Cancer Institute. #MedEd With rapid advancements, staying informed is more important than ever! ?? Read more here: https://hubs.li/Q03dT-5-0
-
Genetic and genomic testing guide #BreastCancer risk assessment and treatment, as discussed by Dr. Mark Robson at the Miami Breast Cancer Summit. #MBCC25 Read more here: https://hubs.li/Q03dYKlf0
-
?? Fruzaqla + sintilimab slows disease progression in the FRUSICA-2 trial, potentially representing a significant advancement in patients with advanced #RenalCellCarcinoma. Full results coming soon! #KidneyCancer #MedEd ?? Key Findings: ? Met primary endpoint of PFS ? Improved response rates Read more here: https://hubs.li/Q03dT1k20
-
The FDA approved neoadjuvant Imfinzi, gemcitabine and cisplatin, followed by adjuvant Imfinzi after radical cystectomy in muscle invasive #BladderCancer. Read more here: https://hubs.li/Q03dZSrf0
-
-
The FDA expands Pluvicto indication to adults with PSMA+ metastatic castration-resistant #ProstateCancer previously treated with androgen receptor inhibitors. Read more here: https://hubs.li/Q03dXzPs0
-